Rheumatoid arthritis - tocilizumab: appraisal consultation (1st October 2009)
The Department of Health asked the National Institute for Health and Clinical Excellence (NICE) to produce guidance on using tocilizumab for the treatment of rheumatoid arthritis in the NHS in England and Wales. The Appraisal Committee considered the evidence submitted by the manufacturer and the views of non-manufacturer consultees and commentators, and clinical specialist and patient experts.
This document has been prepared for consultation with the consultees. It summarises the evidence and views that have been considered, and sets out the draft recommendations made by the Committee.
Closing date for comments is 22nd October 2009.
Consultation
Constipation in children: guideline consultation (1st October 2009)
A clinical practice guideline on Constipation in children is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via the NICE website.
Closing date for comments is 25th November 2009.
Consultation
Identification and care pathways for common mental health disorders: scope consultation (2nd October 2009)
NICE have been asked to develop a clinical practice guideline on Common mental health disorders: identification, assessment and care pathways for common mental health disorders for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Registered stakeholders for the Common mental health disorders: identification and care pathways guideline are invited to submit comments on the scope and may suggest clinical questions that could be answered in the guideline.
Closing date for comments is 30th October 2009.
Consultation
Consultation on NICE response to Kennedy Report (October 2009)
NICE is now inviting comments on its response to Professor Sir Ian Kennedy’s report Appraising the Value of Innovation.
Closing date for comments is 13th January 2010.
Consultation
The Department of Health asked the National Institute for Health and Clinical Excellence (NICE) to produce guidance on using tocilizumab for the treatment of rheumatoid arthritis in the NHS in England and Wales. The Appraisal Committee considered the evidence submitted by the manufacturer and the views of non-manufacturer consultees and commentators, and clinical specialist and patient experts.
This document has been prepared for consultation with the consultees. It summarises the evidence and views that have been considered, and sets out the draft recommendations made by the Committee.
Closing date for comments is 22nd October 2009.
Consultation
Constipation in children: guideline consultation (1st October 2009)
A clinical practice guideline on Constipation in children is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via the NICE website.
Closing date for comments is 25th November 2009.
Consultation
Identification and care pathways for common mental health disorders: scope consultation (2nd October 2009)
NICE have been asked to develop a clinical practice guideline on Common mental health disorders: identification, assessment and care pathways for common mental health disorders for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Registered stakeholders for the Common mental health disorders: identification and care pathways guideline are invited to submit comments on the scope and may suggest clinical questions that could be answered in the guideline.
Closing date for comments is 30th October 2009.
Consultation
Consultation on NICE response to Kennedy Report (October 2009)
NICE is now inviting comments on its response to Professor Sir Ian Kennedy’s report Appraising the Value of Innovation.
Closing date for comments is 13th January 2010.
Consultation
Alcohol-use disorders (prevention): consultation on the draft guidance (13th October 2009)
NICE is developing public health programme guidance (Alcohol-use disorders: preventing the development of hazardous and harmful drinking).
All registered stakeholders for the above public health programme guidance are invited to comment on the draft guidance.
Closing date for comments is 10th November 2009.
Consultation
NICE is developing public health programme guidance (Alcohol-use disorders: preventing the development of hazardous and harmful drinking).
All registered stakeholders for the above public health programme guidance are invited to comment on the draft guidance.
Closing date for comments is 10th November 2009.
Consultation
Latest Implementation Tools (14th October 2009)
Tools to aid implementation of latest NICE guidance.
CG89 When to suspect child maltreatment: Audit Support
TA179 Gastrointestinal stromal tumours - sunitinib: Costing Template and Audit Support
TA181 Lung Cancer (non-small cell, first line treatment) - pemetrexed: Costing Template and Audit Support
TA180 Psoriasis - ustekinumab: Costing Statement and Audit Support
PH20 Social and emotional wellbeing in secondary education: Costing Statement and Slide Set
PH21 Reducing the differences in the uptake of immunisations: Costing Statement
IPG316 Extracorporeal albumin dialysis for acute liver failure: Audit Support
Tools to aid implementation of latest NICE guidance.
CG89 When to suspect child maltreatment: Audit Support
TA179 Gastrointestinal stromal tumours - sunitinib: Costing Template and Audit Support
TA181 Lung Cancer (non-small cell, first line treatment) - pemetrexed: Costing Template and Audit Support
TA180 Psoriasis - ustekinumab: Costing Statement and Audit Support
PH20 Social and emotional wellbeing in secondary education: Costing Statement and Slide Set
PH21 Reducing the differences in the uptake of immunisations: Costing Statement
IPG316 Extracorporeal albumin dialysis for acute liver failure: Audit Support
No comments:
Post a Comment